| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000029935 |
| Receipt No. | R000034198 |
| Official scientific title of the study | Cerebral Blood Flow Measurement of MRI using PSO17 in Normal Subjects |
| Date of disclosure of the study information | 2017/11/16 |
| Last modified on | 2018/11/13 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Cerebral Blood Flow Measurement of MRI using PSO17 in Normal Subjects | |
| Title of the study (Brief title) | Cerebral Blood Flow Measurement using PSO17 | |
| Region |
|
|
| Condition | ||
| Condition | brain infarction, brain tumor, epilepsy | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Comparison of PSO17 concentrations calculated by MRI signals with concentrations of arterial blood |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Phase I |
| Assessment | |
| Primary outcomes | Correlation of PSO17 concentrations between calculated by MRI signals and of arterial blood sampling |
| Key secondary outcomes | 1) Qualitative comparison of PSO17 concentrations calculated by MR signals and of arterial blood sampling
2) vital signs (blood pressure, heart rate, and body temperature) 3) adverse effect |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | intravenous administration of PSO17 and arterial blood collection | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) healthy Japanese (20 - 65 years old)
(2) body weight < 80 kg (3) informed consent is obtained |
|||
| Key exclusion criteria | (1)metallic implant or claustrophobia
(2)blood flow abnormality by Allen test (3)chronic disorders (4)CNS, liver, kidney or heart disease (5)acute infection before 30 days (6)drug allergy (7)chronic intake of drugs (> 30 days) (8)other clinical trial within 90 days (9)willing to have babies or during breast feeding |
|||
| Target sample size | 10 | |||
| Research contact person | |
| Name of lead principal investigator | Kohsuke Kudo |
| Organization | Hokkaido University Hospital |
| Division name | department of diagnostic and interventional radiology |
| Address | Kita 14 Nishi 5, Kita-ku, Sapporo, Hokkaido |
| TEL | 011-706-7779 |
| kkudo@huhp.hokudai.ac.jp | |
| Public contact | |
| Name of contact person | Kohsuke Kudo |
| Organization | Hokkaido University Hospital |
| Division name | department of diagnostic and interventional radiology |
| Address | Kita 14 Nishi 5, Kita-ku, Sapporo, Hokkaido |
| TEL | 011-706-7779 |
| Homepage URL | |
| kkudo@huhp.hokudai.ac.jp | |
| Sponsor | |
| Institute | Hokkaido University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Agency for Medical Research and Development (AMED)/Translational Research Network Program |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 北海道大学病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000034198 |